KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Acquisitions (2016 - 2025)

Johnson & Johnson's Acquisitions history spans 17 years, with the latest figure at $3.0 billion for Q4 2025.

  • For Q4 2025, Acquisitions rose 304000.0% year-over-year to $3.0 billion; the TTM value through Dec 2025 reached $17.5 billion, up 15.54%, while the annual FY2025 figure was $17.5 billion, 15.54% up from the prior year.
  • Acquisitions for Q4 2025 was $3.0 billion at Johnson & Johnson, up from $1.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $17.7 billion in Q1 2023 and bottomed at $1.0 million in Q4 2024.
  • The 5-year median for Acquisitions is $2.4 billion (2024), against an average of $5.7 billion.
  • The largest YoY upside for Acquisitions was 304000.0% in 2025 against a maximum downside of 99.7% in 2025.
  • A 5-year view of Acquisitions shows it stood at $6.4 billion in 2021, then tumbled by 96.05% to $252.0 million in 2022, then soared by 6904.76% to $17.7 billion in 2023, then tumbled by 99.99% to $1.0 million in 2024, then soared by 304000.0% to $3.0 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Acquisitions are $3.0 billion (Q4 2025), $1.0 million (Q3 2025), and $14.5 billion (Q2 2025).